Fig. 1.

Correlation between difference in dose timing of insulin glargine U100 and glycated hemoglobin (HbA1c) level (a, d), fasting plasma glucose level (b, e) and frequency of hypoglycemia (c, f) in persons with type 1 diabetes (a–c) and type 2 diabetes (d–f). * Significantly different at p < 0.05